Blog
Breakthrough: Blockers Unveiled for Cancer Therapy’s Brain Side Effects
🚩 German researchers find causes of CNS side effects in cancer therapy, develop blockers to protect against cognitive deficits.
Fujifilm Diosynth Invests $12B in Massive NC Expansion
📢 Fujifilm Diosynth Biotechnologies invests $1.2B to expand biomanufacturing facility in NC, creating 680 new jobs. 🏭💼🌍📈
Solugen Secures $2136M for Green Production Facility
📢 Solugen receives $213.6M commitment from U.S. Department of Energy to build a biobased production facility in Minnesota. 🏭🌱👷✅
Revolutionizing Oral Biologic Delivery: Tiny VHH Antibodies
🔍 Discover how VHH antibodies could revolutionize oral delivery of biologics, overcoming challenges for better absorption and stability.
Revolutionizing Drug Manufacturing with Data Analysis
💊🔬 Rethinking Data in Drug Manufacturing: The FoReSight framework transforms raw data into actionable information for decision-making. 🧪📊💡📚
Revolutionary Approach to Manufacturing Macrophages
🧪💡✨ Meeting the Challenge of Manufacturing Macrophages explores how Resolution Therapeutics overcomes obstacles to produce effective macrophage therapy.
Revolutionizing Bioprocessing with Advanced Imaging
🔍 Ongoing advances in computer architecture and data analysis are revolutionizing bioprocessing, making imaging an essential tool. 🌱📊👩🔬
Game-Changing Protein Purification Method Unveiled
🔬🧪 Researchers at Queen's University in Canada are developing a cost-effective alternative to Ni-NTA for protein purification using polyphosphate (polyP). 📰
Evotec SE Makes €20m Cash Milestone
💰 Evotec SE celebrates €20m milestone payment from partnership with Bristol Myers Squibb! 🎉 Exciting advancements in neurologic disease research!
Tacalyx Raises €14m to Develop Cancer Therapies
1. 🌱 Tacalyx raises €14m in seed financing to develop anti-TACA cancer therapies. Exciting advancements in cancer treatment! 💪🔬🎗️ 2. Tacalyx secures €14m in seed capital financing, led by Thuja Capital. Promising developments in anti-TACA cancer therapies. 🌟💰🔬
